Latest News about BIIB
Recent news which mentions BIIB
Tickers
BIIB
From Motley Fool
3 Stocks to Buy Where Wall Street Is Focused on Fear
October 07, 2021
From InvestorPlace
3 Biotech Stocks That Could Make You Richer in October and Beyond
October 07, 2021
From Motley Fool
From Benzinga
Rising Oil Prices and Yields Makes Market Navigation More Complex
October 05, 2021
From Benzinga
Here's What to Do When a Stock You Own Sparks Controversy
October 05, 2021
From Motley Fool
Here's What Warren Buffett Looks For With Healthcare Stocks
October 02, 2021
From Motley Fool
Cassava Stock Has Reached a Positive Turning Point
October 01, 2021
From InvestorPlace
See Why Perrigo Shares Are Moving Higher On Thursday
September 30, 2021
From Benzinga
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
September 29, 2021
From MarketWatch
3 Biotech Stocks With Huge Catalysts This Fall
September 29, 2021
From Motley Fool
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
September 28, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
Is Cassava Sciences Back in the Game?
September 28, 2021
From Motley Fool
Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More
September 25, 2021
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
September 23, 2021
Tickers
BIIB
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
From Benzinga
Thinking About Buying Stock Or Options In Tesla, Ballard Power, Bloom Energy Or Biogen?
September 23, 2021
From Benzinga
From Benzinga
Is Now the Time to Ditch Pharma Stocks?
September 21, 2021
From Motley Fool
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
September 18, 2021
From Motley Fool
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Biogen Reports Mixed Phase 2 Data For Its Non-Opioid Pain Candidate
September 16, 2021
Tickers
BIIB
From Benzinga
Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know
September 15, 2021
From Benzinga
3 Quality Stocks to Buy From the Bargain Bin
September 13, 2021
From InvestorPlace
Cassava Stock Is a Bold Play That Could Pay Off Soon
September 13, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.